Literature DB >> 9653969

Simultaneous determination of the stereoisomers of guggulsterone in serum by high-performance liquid chromatography.

N Verma1, S K Singh, R C Gupta.   

Abstract

Simultaneous separation of E- and Z-guggulsterone, which is the main ingredient of 'Guggulip', an ayurvedic drug, was accomplished by HPLC on a C18 column using methanol, acetonitrile, buffer and tetrahydrofuran as a mobile phase. The compounds were monitored at 248 nm on a photodiode array detector. The assay method was used for the simultaneous determination of stereoisomers (E and Z) of guggulsterone in spiked serum and dosed (50 mg/kg, p.o.) rats. The recoveries of E- and Z-isomers from serum samples were always greater than 90%. The calibration graph was linear over the range of 25-2500 ng/ml for Z- and E-isomers. Lowest quantitation limit of Z- and E-guggulsterones was 25 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653969     DOI: 10.1016/s0378-4347(97)00626-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  4 in total

1.  Quantitative determination of guggulsterone in existing natural populations of Commiphora wightii (Arn.) Bhandari for identification of germplasm having higher guggulsterone content.

Authors:  Alpana Kulhari; Arun Sheorayan; Ashok Chaudhury; Susheel Sarkar; Rajwant K Kalia
Journal:  Physiol Mol Biol Plants       Date:  2014-11-22

2.  Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

Authors:  Muzafar A Macha; Satyanarayana Rachagani; Suprit Gupta; Priya Pai; Moorthy P Ponnusamy; Surinder K Batra; Maneesh Jain
Journal:  Cancer Lett       Date:  2013-08-03       Impact factor: 8.679

3.  Estimation of Guggulsterone E and Z in the Guggul-based Commercial Formulations Using High-performance Thin-layer Chromatography.

Authors:  Pramod Kumar Sairkar; Anjana Sharma; N P Shukla
Journal:  J Pharm Bioallied Sci       Date:  2017 Jan-Mar

Review 4.  Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer.

Authors:  Sosmitha Girisa; Dey Parama; Choudhary Harsha; Kishore Banik; Ajaikumar B Kunnumakkara
Journal:  Explor Target Antitumor Ther       Date:  2020-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.